These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31513598)

  • 1. Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study.
    Mitchell AJ; Vancampfort D; Manu P; Correll CU; Wampers M; van Winkel R; Yu W; De Hert M
    PLoS One; 2019; 14(9):e0210674. PubMed ID: 31513598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose?
    Yu EY; Wong CK; Ho SY; Wong SY; Lam CL
    Fam Pract; 2015 Dec; 32(6):631-8. PubMed ID: 26467644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients.
    Hjellestad ID; Astor MC; Nilsen RM; Søfteland E; Jonung T
    Cardiovasc Diabetol; 2013 May; 12():79. PubMed ID: 23705980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test - which method to choose for the diagnosis?
    Coelho AR; Moreira FA; Santos AC; Silva-Pinto A; Sarmento A; Carvalho D; Freitas P
    BMC Infect Dis; 2018 Jul; 18(1):309. PubMed ID: 29980190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans.
    Nguyen KA; Peer N; de Villiers A; Mukasa B; Matsha TE; Mills EJ; Kengne AP
    PLoS One; 2019; 14(1):e0211483. PubMed ID: 30703147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs.
    Manu P; Correll CU; Wampers M; van Winkel R; Yu W; Mitchell AJ; De Hert M
    Eur Neuropsychopharmacol; 2013 Mar; 23(3):205-11. PubMed ID: 22652493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
    Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
    BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.
    Prakaschandra R; Naidoo DP
    Ethn Dis; 2018; 28(1):19-24. PubMed ID: 29467562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
    ; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
    J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence-a population-based survey of 6898 Han participants from southern China.
    Huang H; Peng G; Lin M; Zhang K; Wang Y; Yang Y; Zuo Z; Chen R; Wang J
    Prev Med; 2013 Oct; 57(4):345-50. PubMed ID: 23777673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening with HbA1c identifies only one in two individuals with diagnosis of prediabetes at oral glucose tolerance test: findings in a real-world Caucasian population.
    Chilelli NC; Cosma C; Ragazzi E; Burlina S; Zaninotto M; Plebani M; Lapolla A
    Acta Diabetol; 2014 Oct; 51(5):875-82. PubMed ID: 25192952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
    Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
    Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
    Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
    Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.
    Karayiannides S; Djupsjö C; Kuhl J; Hofman-Bang C; Norhammar A; Holzmann MJ; Lundman P
    Cardiovasc Diabetol; 2021 Jun; 20(1):122. PubMed ID: 34126971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan.
    Matsumoto N; Arase Y; Kawamura Y; Ohmoto-Sekine M; Amakawa K; Ogawa K; Tsuji H; Dong HS; Hara S; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Kumada H; Kobayashi T
    Intern Med; 2015; 54(8):875-80. PubMed ID: 25876566
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.